ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 198

$349K Total Retail Price of All Prescriptions

Rank: 95 out of 198

351 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,149 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 443 418 1 2
LISINOPRIL 239 222 2 6
OMEPRAZOLE 229 220 3 3
HYDROCODONE-ACETAMINOPHEN 212 180 S3 4 8
LEVOTHYROXINE SODIUM 212 200 4 1
FUROSEMIDE 170 165 6 5
METOPROLOL TARTRATE 166 159 7 10
HYDROCHLOROTHIAZIDE 154 153 8 16
WARFARIN SODIUM 151 136 9 7
AMLODIPINE BESYLATE 146 142 10 4
SERTRALINE HCL 132 109 11 25
METFORMIN HCL 128 120 12 13
METOPROLOL SUCCINATE 123 116 13 11
POTASSIUM CHLORIDE 122 122 14 9
TAMSULOSIN HCL 112 111 15 27
TRAMADOL HCL 110 109 16 15
DONEPEZIL HCL 107 107 17 28
TRAZODONE HCL 103 99 18 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 92 19 38
GABAPENTIN 93 64 20 14
LOSARTAN POTASSIUM 78 78 21 18
ALLOPURINOL 72 67 22 23
ADVAIR DISKUS 66 54 23 47
FENOFIBRATE 64 57 24 61
ALENDRONATE SODIUM 63 62 25 21
GLYBURIDE 60 57 R 26 103
FLUTICASONE PROPIONATE 58 54 27 39
AMLODIPINE BESYLATE-BENAZEPRIL 57 46 28 99
GLIPIZIDE 55 55 29 62
AMITRIPTYLINE HCL 52 44 R 30 69
NIASPAN 51 51 31 138
ZOLPIDEM TARTRATE 51 49 31 22
LOSARTAN-HYDROCHLOROTHIAZIDE 50 44 33 49
FINASTERIDE 50 50 33 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.